COVID-19 Impact on Global Atenolol Market
- On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 214 countries and territories around the world.
- Several governments and private sector businesses are operating at a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic
- The outbreak of the COVID-19 pandemic has led to disturbance in the supply chain due to the global lockdown in several countries. Also, the spread of the coronavirus has led to a fall in demand for chemical intermediates due to uncertainty in the global economy and capital markets.
- The atenolol market has been negatively affected due to the COVID-19 pandemic and nationwide lockdown of several non-essential activities and manufacturing facilities. However, the market is anticipated to expand during the forecast period due to the acceptance of new normal conditions and restart of end-use industries in various countries across the globe.
Key Drivers and Restraints of Atenolol Market
- Demand for atenolol is expected to increase at a significant pace during the forecast period due to rise in incidence of hypertension across the globe. Increase in geriatric population and sedentary lifestyle is boosting the atenolol market.
- Rise in awareness about complications associated with hypertension is a major factor that is fueling the atenolol market
- Atenolol can cause severe allergic reactions. This is expected to negatively affect the atenolol market.
Atenolol Market: Application Segment
- Based on application, the atenolol market can be divided into hypertension, angina, arrhythmia, and others. Of these, the hypertension segment dominates the atenolol market.
- Strong demand for antihypertensive drugs in the global market is expected to drive the atenolol demand during the forecast period
Atenolol Market: Distribution Channel Segment
- In terms of distribution channel, the atenolol market can be segregated into retail pharmacy, hospital pharmacy, and e-commerce. Of these, the hospital pharmacy segment dominates the atenolol market. This can be ascribed to the rise in number of hospitals worldwide.
- The e-commerce segment is expected to exhibit rapid growth rate during the forecast period, owing to surge in the usage of Internet across the globe
Asia-Pacific to Hold Leading Share of Global Atenolol Market
- In terms of region, the atenolol market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- Asia Pacific is expected to hold major share of the global atenolol market, followed by North America and Europe, during the forecast period
- According to the World Health Organization, 1.13 billion individuals worldwide had hypertension in 2018, of which two-third resided in low income and developing countries. Over the past decade, the global burden of hypertension has increased, primarily driven by a significant rise in population, lifestyle changes, and increase in the geriatric population worldwide. In the current scenario, hypertension is effectively controlled in less than 20% of the patients across the world, which means there is a mounting demand for antihypertensive drugs, particularly in developing regions.
- The market in Asia Pacific is projected to expand at a rapid pace during the forecast period, owing to surge in awareness related to the use of antihypertensive drugs. Furthermore, the constantly evolving life science industry is driving the growth of the market in developing economies such as India, China, and Malaysia.
Key Manufacturers Operating in Global Atenolol Market
The atenolol market was consolidated in 2020. Major players have prominent presence in developed and developing countries. Key manufacturers operating in the atenolol market include:
- AstraZeneca
- ACETO
- Aurobindo Pharma
- Sandoz
- Mylan
- Sun Pharmaceutical
- Teva
- Zydus Pharmaceuticals
- Unique Pharmaceuticals
- Ipca Laboratories
- Intas Pharmaceuticals
Atenolol Market: Research Scope
Atenolol Market, by Product Type
Atenolol Market, by Application
- Hypertension
- Angina
- Arrhythmia
- Others
Atenolol Market, by Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
Global Atenolol Market, by Region
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia & CIS
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Atenolol Market: Introduction
- Atenolol is a medication of the beta blockers type. It is used to treat high blood pressure and chest pain. It can also help prevent heart attack; or heart damage after a heart attack.
- Atenolol is primarily used as an antihypertensive drug. Hypertension is a critical health condition that can lead to cardiovascular diseases, renal failure, stroke, and even death.
